NextCure Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.17	25.98	27.73	13.08	26.63	12.34
Short-Term Investments	14.58	15.84	40.89	95.22	133.28	207.25
Cash & Short-Term Investments	29.74	41.82	68.62	108.3	159.91	219.59
Cash Growth	-46.75%	-39.06%	-36.64%	-32.27%	-27.18%	-22.53%
Other Current Assets	2	1.93	3.19	4.43	4.07	8.23
Total Current Assets	31.74	43.75	71.81	112.73	163.98	227.82
Net Property, Plant & Equipment	5.39	5.89	8.72	13.43	16.91	13.99
Other Long-Term Assets	0.85	0.55	0.33	1.88	3.27	0.58
Total Assets	37.98	50.18	80.86	128.04	184.16	242.39
Accounts Payable	3.07	2.01	5.35	2.33	4.27	1.94
Accrued Expenses	3.82	8.56	4.22	4.55	4.86	4.67
Total Current Liabilities	6.89	10.57	9.57	6.88	9.13	6.61
Long-Term Leases	3.88	4.15	5.15	5.95	6.61	-
Other Long-Term Liabilities	0.49	0.53	0.66	0.79	0.9	2.39
Total Long-Term Liabilities	4.37	4.67	5.81	6.73	7.5	2.39
Total Liabilities	11.26	15.24	15.39	13.62	16.63	9
Common Stock	0	0	0	0.03	0.03	0.03
Additional Paid-in Capital	472.49	470.9	445.6	439.1	430.76	421.05
Accumulated Other Comprehensive Income	-0	0.02	0	-0.22	-1.49	-0.66
Retained Earnings	-445.78	-	-	-	-	-
Shareholders' Equity	26.72	470.92	445.61	438.9	429.29	420.41
Total Liabilities & Equity	37.98	50.18	80.86	128.04	184.16	242.39
Total Debt	3.88	4.15	5.15	5.95	6.61	0
Net Cash (Debt)	25.86	37.67	63.47	102.35	153.31	219.59
Net Cash Growth	-31.34%	-40.65%	-37.99%	-33.24%	-30.19%	-21.57%
Net Cash Per Share	7.25	13.25	27.23	44.12	66.31	95.42
Book Value	26.72	470.92	445.61	438.9	429.29	420.41
Book Value Per Share	7.49	165.68	191.22	189.21	185.68	182.68
Tangible Book Value	26.72	470.92	445.61	438.9	429.29	420.41
Tangible Book Value Per Share	7.49	165.68	191.22	189.21	185.68	182.68

SEC Filings: 10-K · 10-Q